Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn moreSpecies
Alpha Genesis supports GLP and non-GLP studies in both rats (Rattus norvegicus) and mice (Mus musculus), generating rodent data that supports North American and global development programs. Programs span PK/PD profiling, dose-ranging, toxicology, immunology, oncology, and surgical models, with serial and terminal biospecimen collection and structured in-life monitoring.
Rodent models remain the most widely used platform in preclinical research, underpinning early-stage screening, mechanistic investigation, regulatory dose-ranging, and translational validation. Mice and rats offer well-characterized pharmacology, genetic tractability, a broad commercial strain portfolio, and established regulatory acceptance across therapeutic areas and across U.S. and international regulatory programs.
Alpha Genesis delivers GLP and non-GLP rodent study support across PK/PD, safety toxicology, dose-ranging, immunology, oncology, and surgical models in both rat (Rattus norvegicus) and mouse (Mus musculus). Experienced rodent technicians execute dosing, serial and terminal biospecimen collection, and structured in-life monitoring under rigorous, consistent husbandry and veterinary oversight, the operational discipline that drives study reproducibility, because excellent welfare is fundamental to excellent science. Facilities are AAALAC accredited, USDA registered, OLAW assured, and supported by IACUC oversight and experienced veterinary care, with study documentation consistent with internationally recognized GLP expectations.
We support GLP and non-GLP rodent studies in both rats and mice, generating data suited to global IND-enabling and regulatory programs and to the translational transition from rodent studies into NHP work. Specific study scope, model availability, and timeline feasibility are aligned during early protocol consultation to ensure fit before program commitment.
Rodent in vivo programs at Alpha Genesis serve sponsors across the preclinical development spectrum.
Sponsors requiring early-stage efficacy screening, IND-enabling dose-ranging, GLP and non-GLP safety studies, and PK/PD profiling in mouse and rat models to support drug development decisions across North American and global development programs.
Investigator-led programs in oncology, immunology, neuroscience, and pharmacology requiring in vivo rodent models, flexible study designs, and biospecimen access.
Countermeasure, infectious disease, and vaccine programs using rodent models as part of a multi-species research strategy.
Contract research organizations seeking rodent study capacity, specialized surgical capabilities, or biospecimen collection to complement their own program portfolios.
Rodent in vivo capabilities at Alpha Genesis span study types commonly employed across early-stage and regulatory preclinical research.
Rodent study engagements are scoped during protocol review to confirm study design, model selection, GLP applicability, and timeline.
GLP rodent studies are available in both rats and mice. Applicability depends on study design, objectives, and current facility qualifications. Protocol submission is required to confirm GLP suitability.
Non-GLP mouse and rat studies for early-stage screening, mechanistic investigation, proof-of-concept, and translational research, with structured documentation and data reporting.
Serial and terminal biospecimen collection from rodent studies, including blood, serum, plasma, tissue, tumor, and organ samples. Sample processing, cryopreservation, and chain-of-custody documentation included.
Rodent studies are conducted under SOP-driven procedures by trained rodent technicians with veterinary oversight across all phases of in-life conduct.
Rigorous, consistent husbandry and disciplined in-life conduct are what make rodent data reproducible, compliance is the baseline beneath that. Alpha Genesis’s rodent programs run within a full regulatory framework backed by experienced veterinary oversight.
Alpha Genesis operates dedicated rodent in vivo capabilities for both rats and mice, building on its NHP expertise to provide sponsors with integrated multi-species preclinical support under one compliance umbrella.
GLP and non-GLP rodent study support available for qualified programs, supporting seamless transitions from early-stage screening to regulatory-track study execution, with documentation consistent with internationally recognized GLP expectations for global development programs.
Rodent programs run under veterinary oversight with consistent husbandry, defined humane endpoints, and clinical monitoring that protect both animal welfare and data quality.
Trained rodent technicians performing dosing, serial collection, surgical procedures, and in-life monitoring under SOP-governed conditions with structured documentation.
For sponsors running parallel rodent and NHP programs, Alpha Genesis offers a single CRO partner experienced in both, enabling efficient, scientifically appropriate transition from rodent studies into NHP work under consistent standards.
SOP-driven operations with sponsor audit readiness, structured data records, and chain-of-custody documentation supporting regulatory review and inspection readiness.
All common rodent strains are available, inbred, outbred, and specialized. We source from qualified vendors meeting our health standards and confirm the specific strain for your program during protocol review.
Our scientific and operations team is available to review your protocol objectives, assess study design feasibility, and confirm GLP or non-GLP applicability for your rodent in vivo program.
